Health Care/Hospital
Zhejiang Hisun Pharmaceutical: COVID-19 Pandemic Brought Under Control in China With Favipiravir Showing Excellent Clinical Results
TAIZHOU, China, June 30, 2020 /PRNewswire/ -- COVID-19 has become a global pandemic.China's successful control of the pandemic has set a good example for other countries. Many have followedChina to take effective measures like enforcing lockdowns and wearing masks have all been proved to be effec...
2020-06-30 18:51
2468
Shangri-La Partners With Diversey to Upcycle 12,500kg of Hotel Linen Into Half-a-million Reusable Face Masks for the Vulnerable
SINGAPORE, June 30, 2020 /PRNewswire/ -- Vulnerable members in communities across 11 cities inSoutheast Asia and Sri Lanka will soon have greater access to reusable face masks with the regional Linens For Life Face Masks (L4LFM) partnership between Shangri-La Group and Diversey, a leading global ...
2020-06-30 15:51
2690
Release of Initial Attana Virus Analytics-AVA Testing Protocols
STOCKHOLM, June 30, 2020 /PRNewswire/ -- Attana has today released the initial technical protocols for AVA Antibody Testing and will make these available to all existing Attana customers. In close collaboration with Linnaeus University Attana application specialists have been performing studies ...
2020-06-30 15:42
1263
'Curing Cancer without Surgery'
* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer drug, Polytaxel, without side effects such as weight loss." * Suppressed 99.8% of tumors despite a non-toxic dose…more effective than existing FDA-approved pancreatic cancer drugs. * Hopes for a Kore...
2020-06-30 15:10
1512
Sweeping Workplace Changes Expected in a Post-pandemic World, Says Research From The Adecco Group
ZURICH, June 30, 2020 /PRNewswire/ -- * Workers demand greater flexibility after coronavirus, with a 50/50 split of remote and office time confirmed as the universal ideal * Questions raised over the hours-based contract, with 69% saying contracts should be based on results delivered rather t...
2020-06-30 15:00
3083
Santen and Singapore's Health-tech Start-up, Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia
OSAKA, Japan and SINGAPORE, June 30, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter, Santen) and Plano Pte. Ltd (hereinafter, Plano) today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from S...
2020-06-30 15:00
1907
Thrombosis Research Institute (TRI) Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19
- Clinical trial will recruit approximately 1400 patients in 10 countries starting in July - Participants will be randomised to receive the low molecular weight Heparin enoxaparin or current standard of care for up to 3 weeks from the time of diagnosis - The study is supported through an inve...
2020-06-30 14:00
1814
AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis: Initiates Phase 2b Clinical Trial in Adults
AOBiome's 576 patient Phase 2b trial commences patient enrollment CAMBRIDGE, Massachusetts, June 30, 2020 /PRNewswire/ -- AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammation, announced initiation of a Phase2b clinical trial in pruritus (i...
2020-06-30 13:00
1151
Art Travel Shoe Brand UIN Footwear Gives Away Shoes to Frontline Nurses Worldwide
BARCELONA, Spain, June 30, 2020 /PRNewswire/ -- Nurses and healthcare workers are the heroes of our time. Every day for months they have been risking their lives to stand by our bedsides, helping and caring for us during this global coronavirus pandemic. Now UIN Footwear is recognizing their effo...
2020-06-30 12:10
1583
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434
MELBOURNE, Australia and SAN FRANCISCO, June 29, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce that it has received guidance from the US Food and Drug Administration (FDA) in relation to the development pathway for ATH434 ...
2020-06-30 11:14
5988
DXIN Joins Hands with TCI to Develop a Variety of Premium Functional Foods for Beauty Purposes
NEW YORK, June 29, 2020 /PRNewswire/ -- DXIN (Dong & Xing), a well-known brand
inChina, has seen rapid growth over the past 6 years and become a striking
leader in global skin care market.
2020-06-30 10:32
2986
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon
NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent ...
2020-06-30 08:00
2231
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020
Added 18,488 New Subscribers in 4Q20 4Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million) 4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million) Non-GAAP Operating Income Up 58.7% YoY to RMB161.7 Million ($22.8 Million) Conference Call to be Held on Jun...
2020-06-30 04:16
13648
RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19
Under Way in Europe Since May, In Preparation in the U.S. Designated As An Urgent Public Health National Priority In U.K. BETHESDA, Maryland, June 29, 2020 /PRNewswire/ -- RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and cancer, an...
2020-06-29 21:00
2457
How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help
PLYMOUTH MEETING, Pennsylvania, June 29, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Immunotherapy Side Effects--Immune Checkpoint Inhibitors. Over the past decade, immunotherapy--a treatment that h...
2020-06-29 20:47
2649
Shangri-La Hotel first in Singapore to receive SafeGuard Hygiene Excellence and Safety Label by Bureau Veritas
SINGAPORE, June 29, 2020 /PRNewswire/ -- With Singapore entering phase two of reopening and moving towards a new normal, guests can enjoy even greater peace of mind the next time they visit and dine at Shangri-La Hotel,Singapore. The hotel is the proud recipient ofSingapore's first SafeGuard Hygi...
2020-06-29 15:36
2320
Wealth sharing campaign spreading in Suncheon to aid coronavirus victims
SUNCHEON, South Korea, June 29, 2020 /PRNewswire/ -- A wealth sharing campaign
has been spreading in Suncheon, a city about 415 kilometers south ofSeoul, to
support underprivileged citizens hit hard by the coronavirus outbreak.
According to the municipality of Suncheon saidon Friday.
2020-06-29 14:58
3383
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction
BEIJING, June 29, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that the Company disagrees with the notice delivered by Xinjiang Deyuan Bioeng...
2020-06-29 13:00
11910
Picosun's Medical ALD Solutions Ensure Excellent Hermetic Encapsulation
ESPOO, Finland, June 29, 2020 /PRNewswire/ -- Picosun Group reports excellent results in ALD-organic bilayer encapsulation of metal electrodes for neuroprosthetics and bioelectronic medicine. Group also reports superior hermetic barrier performance of its ALD nanolaminates against corrosive ion ...
2020-06-29 11:34
1304
Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board
SHANGHAI, June 29, 2020 /PRNewswire/ -- Chinese insulin manufacturer Gan & Lee Pharmaceuticals (SHSE: 603087), Qiming's portfolio company today lands on the A-shares main board market. The issue price of Gan & Lee isRMB 63.32 per share. The stock opens atRMB 91.18 per share, up 44%, with a market...
2020-06-29 11:31
3327
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8288
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7685